AUD 0.02
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | -38.34 Million AUD | -83.38% |
2023 | -20.91 Million AUD | -14.54% |
2022 | -15.29 Million AUD | -81.1% |
2021 | -4.55 Million AUD | -173.31% |
2020 | 19.44 Million AUD | 219.97% |
2019 | 4.05 Million AUD | 137.15% |
2018 | -10.88 Million AUD | -18.18% |
2017 | -9.17 Million AUD | -148.02% |
2016 | -3.72 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q4 | -8.25 Million AUD | -120.71% |
2024 FY | - AUD | 41.71% |
2024 Q2 | -4.34 Million AUD | -184.26% |
2023 Q2 | -15.08 Million AUD | -63.07% |
2023 Q4 | -4.62 Million AUD | 69.36% |
2023 FY | - AUD | -14.54% |
2022 FY | - AUD | -81.1% |
2022 Q4 | -9.25 Million AUD | -16.29% |
2022 Q2 | -7.95 Million AUD | -76.78% |
2021 Q2 | -5 Million AUD | -234.75% |
2021 FY | - AUD | -173.31% |
2021 Q4 | -4.5 Million AUD | 10.02% |
2020 Q4 | 3.71 Million AUD | -59.87% |
2020 FY | - AUD | 219.97% |
2020 Q2 | 9.25 Million AUD | 79.51% |
2019 Q4 | 5.15 Million AUD | 567.6% |
2019 Q2 | -1.1 Million AUD | 82.03% |
2019 FY | - AUD | 137.15% |
2018 Q4 | -6.13 Million AUD | -29.22% |
2018 FY | - AUD | -18.18% |
2018 Q2 | -4.74 Million AUD | 0.0% |
2017 FY | - AUD | -148.02% |
2016 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Althea Group Holdings Limited | -28.56 Million AUD | -34.253% |
Cann Group Limited | -35.53 Million AUD | -7.902% |
ECS Botanics Holdings Ltd | 3.22 Million AUD | 1287.748% |
Elixinol Wellness Limited | -6.8 Million AUD | -463.385% |
Hygrovest Limited | -1.1 Million AUD | -3376.337% |
IDT Australia Limited | -5.13 Million AUD | -647.01% |
Invion Limited | -4.57 Million AUD | -738.716% |
Little Green Pharma Ltd | -4.64 Million AUD | -725.789% |
Live Verdure Ltd | -12.51 Million AUD | -206.471% |
Medical Developments International Limited | -29.44 Million AUD | -30.218% |
Vitura Health Limited | 7.07 Million AUD | 641.868% |
Vita Life Sciences Limited | 13.09 Million AUD | 392.747% |